EMILY CULLER: Open Payments
NPI 1306575550 · CAMDEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 99 payments from 27 companies in 2025. Trend: 2023 $1,030 · 2024 $1,295 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $213 |
| Novo Nordisk Inc | 13 | $189 |
| AstraZeneca Pharmaceuticals LP | 8 | $175 |
| PFIZER INC. | 7 | $134 |
| Abbott Laboratories | 5 | $77 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| Dexcom, Inc. | 3 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Amgen Inc. | 3 | $52 |
Products named: NURTEC ODT, AIRSUPRA, VRAYLAR, FREESTYLE LIBRE 3, FARXIGA, CAPLYTA, Dexcom G6 Transmitter, Wegovy.
Industry payments across SC — which companies pay providers there.
